| Literature DB >> 34294840 |
Zih-Ting Chang1, Yu-Feng Huang2, Yue-Wen Chen1, Ming-Ren Yen3, Po-Ya Hsu1, Tzu-Han Chen3, Yi-Hsuan Li3, Kuo-Ping Chiu2, Yu-Shin Nai4.
Abstract
Deformed wing virus (DWV) prevalence is high in honey bee (Apis mellifera) populations. The virus infects honey bees through vertical and horizontal transmission, leading to behavioural changes, wing deformity, and early mortality. To better understand the impacts of viral infection in the larval stage of honey bees, artificially reared honey bee larvae were infected with DWV (1.55 × 1010 copies/per larva). No significant mortality occurred in infected honey bee larvae, while the survival rates decreased significantly at the pupal stage. Examination of DWV replication revealed that viral replication began at 2 days post inoculation (d.p.i.), increased dramatically to 4 d.p.i., and then continuously increased in the pupal stage. To better understand the impact of DWV on the larval stage, DWV-infected and control groups were subjected to transcriptomic analysis at 4 d.p.i. Two hundred fifty-five differentially expressed genes (DEGs) (fold change ≥ 2 or ≤ -2) were identified. Of these DEGs, 168 genes were downregulated, and 87 genes were upregulated. Gene Ontology (GO) analysis showed that 141 DEGs (55.3%) were categorized into molecular functions, cellular components and biological processes. One hundred eleven genes (38 upregulated and 73 downregulated) were annotated by KO (KEGG Orthology) pathway mapping and involved metabolic pathways, biosynthesis of secondary metabolites and glycine, serine and threonine metabolism pathways. Validation of DEGs was performed, and the related gene expression levels showed a similar tendency to the DEG predictions at 4 d.p.i.; cell wall integrity and stress response component 1 (wsc1), cuticular protein and myo-inositol 2-dehydrogenase (iolG) were significantly upregulated, and small conductance calcium-activated potassium channel protein (SK) was significantly downregulated at 4 d.p.i. Related gene expression levels at different d.p.i. revealed that these DEGs were significantly regulated from the larval stage to the pupal stage, indicating the potential impacts of gene expression levels from the larval to the pupal stages. Taken together, DWV infection in the honey bee larval stage potentially influences the gene expression levels from larvae to pupae and reduces the survival rate of the pupal stage. This information emphasizes the consequences of DWV prevalence in honey bee larvae for apiculture.Entities:
Year: 2021 PMID: 34294840 PMCID: PMC8298419 DOI: 10.1038/s41598-021-94641-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1A survival curve was constructed based on Kaplan–Meier analysis using the data of the deformed wing virus (DWV) infection (1.55 × 1010 copies/per larva) and noninfection control groups over 22 days (100 larvae/per repeat and total 3 replicates). A significant difference between these groups was observed during all stages in this experiment. Different letters are significantly different (chi-square = 9.785; 1 d.f.; P = 0.002).
Figure 2Detection of DWV infection by (A) RT-PCR and (B) quantitative RT-PCR (qRT-PCR) based on a plasmid standard curve. The samples were collected at 0, 2, 4 and 9 d.p.i. The copies of DWV were increased from 2 d.p.i. to 6 d.p.i. and continuously increased in the pupal stage. Full-length gels are presented in Supplementary Figs. 4 and 5.
Figure 3Overview of the fold change (log2 ratio ≥ 1) distribution of differentially expressed genes (DEGs). (A) Expression levels of the contigs in noninfected and DWV-infected larvae. (B) Analysis of DEGs identified from noninfected and DWV-infected samples. Downregulated genes are shown on the left side, and upregulated genes are shown on the right side. The expressed contigs with fold change ≥ 2 or ≤ -2 are listed, and the contig numbers with corresponding fold change are shown above each bar.
List of upregulated genes (fold change ≥ 4) identified in the DWV-infected honey bee larvae library.
| No | Gene symbol | Location | Annotation | Gene type | Fold change | KO annotation |
|---|---|---|---|---|---|---|
| 1 | LOC102656630 | NC_037639.1 (10986767..10989283) | Uncharacterized LOC102656630 | ncRNA | 34.50 | |
| 2 | LOC725305 | NC_037638.1 (27575255..27577314) | Uncharacterized LOC725305 | Protein coding | 9.59 | |
| 3 | LOC102656570 | NC_037644.1 (9765896..9768671) | Glucose dehydrogenase [FAD, quinone] | Protein coding | 9.59 | |
| 4 | LOC100577585 | NC_037638.1 (6125693..6132159, complement) | Uncharacterized LOC100577585 | Protein coding | 9.39 | |
| 5 | LOC100577331 | NC_037647.1 (5365831..5367042) | Cell wall integrity and stress response component 1 | Protein coding | 7.90 | |
| 6 | LOC113218981 | NC_037646.1 (6584793..6586590, complement) | E3 ubiquitin-protein ligase MARCH8-like | Pseudo | 6.70 | |
| 7 | LOC724464 | NC_037651.1 (1453144..1459475) | Cuticular protein | Protein coding | 6.67 | |
| 8 | LOC552024 | NC_037645.1 (8626452..8629999) | Myo-inositol 2-dehydrogenase | Protein coding | 6.18 | K00010 |
| 9 | LOC113219275 | NC_037638.1 (12578526..12578968, complement) | Uncharacterized LOC113219275 | ncRNA | 5.43 | |
| 10 | LOC551782 | NC_037642.1 (598474..602169, complement) | Bestrophin-4 | Protein coding | 5.17 | K22204 |
| 11 | LOC413924 | NC_037647.1 (10700617..10702820, complement) | Glyceraldehyde-3-phosphate dehydrogenase | Protein coding | 5.11 | K00134 |
| 12 | LOC107965534 | NC_037651.1 (5066923..5068437) | Protein Fer3-like | Protein coding | 4.99 | K22400 |
| 13 | LOC113218572 | NC_037647.1 (10291785..10293155) | Uncharacterized LOC113218572 | Protein coding | 4.87 | |
| 14 | LOC102655275 | NC_037638.1 (11942593..11953074, complement) | Uncharacterized LOC102655275 | ncRNA | 4.70 | |
| 15 | LOC102656842 | NC_037643.1 (13368509..13370515, complement) | Uncharacterized LOC102656842 | ncRNA | 4.40 | |
| 16 | LOC725804 | NC_037645.1 (10430848..10433690, complement) | Cuticle protein 18.7 | Protein coding | 4.24 | |
| 17 | LOC100576935 | NC_037646.1 (8198101..8205488, complement) | Uncharacterized LOC100576935 | Protein coding | 4.05 | |
| 18 | LOC102656669 | NC_037638.1 (12577483..12580393) | Ctenidin-1-like | Protein coding | 4.04 | |
| 19 | LOC113219409 | NC_037638.1 (10363934..10369500) | Uncharacterized LOC113219409 | ncRNA | 4.03 | |
| 20 | LOC100578187 | NC_037638.1 (1968930..1971969, complement) | Uncharacterized LOC100578187 | ncRNA | 4.02 |
List of downregulated genes (fold change ≤ − 4) identified in the DWV-infected honey bee larvae library.
| No | Gene symbol | Location | Annotation | Gene type | Fold change | KO annotation |
|---|---|---|---|---|---|---|
| 1 | LOC107963975 | NC_037638.1 (13283980..13285235) | Uncharacterized LOC107963975 | Protein coding | −29.55 | |
| 2 | LOC102655555 | NC_037647.1 (12296588..12305191, complement) | Uncharacterized LOC102655555 | ncRNA | −15.22 | |
| 3 | LOC413908 | NC_037650.1 (10728080..10731750, complement) | Cytochrome P450 6A1 | Protein coding | −13.29 | K14999 |
| 4 | LOC100576697 | NC_037638.1 (23954915..23963214) | Uncharacterized LOC100576697 | ncRNA | −13.19 | |
| 5 | LOC724565 | NC_037643.1 (3145515..3148360, complement) | Trypsin-7 | Protein coding | −10.97 | |
| 6 | LOC409751 | NC_037651.1 (6389782..6392462) | Multiple inositol polyphosphate phosphatase 1 | Protein coding | −9.14 | K03103 |
| 7 | LOC100577819 | NC_037643.1 (5585899..5588396, complement) | Uncharacterized LOC100577819 | Protein coding | −8.59 | |
| 8 | LOC102656882 | NC_037651.1 (5937498..5939234, complement) | Cytochrome P450 9e2-like | Protein coding | −7.91 | K15003 |
| 9 | Est-6 | NC_037640.1 (9461728..9464050) | Venom carboxylesterase-6 | Protein coding | −7.30 | K12298 |
| 10 | LOC113218894 | NC_037644.1 (10166236..10175388, complement) | Uncharacterized LOC113218894 | ncRNA | −7.27 | |
| 11 | LOC102655781 | NC_037653.1 (4736319..4743867, complement) | Uncharacterized LOC102655781 | ncRNA | −7.05 | |
| 12 | LOC410850 | NC_037639.1 (12443562..12446826) | Coiled-coil domain-containing protein 63-like | Protein coding | −6.75 | K23732 |
| 13 | LOC410317 | NC_037648.1 (11450640..11678693, complement) | Small conductance calcium-activated potassium channel protein | Protein coding | −6.26 | K04944 |
| 14 | LOC725087 | NC_037650.1 (10762729..10766334, complement) | Probable cytochrome P450 6a14 | Protein coding | −5.82 | K14999 |
| 15 | LOC410405 | NC_037650.1 (2519228..2524033) | Cytochrome P450 18a1 | Protein coding | −5.62 | K14985 |
| 16 | LOC102656658 | NC_037644.1 (3642775..3659414, complement) | Uncharacterized LOC102656658 | ncRNA | −5.57 | |
| 17 | LOC410406 | NC_037650.1 (2532325..2536231) | Zinc metalloproteinase nas-13 | Protein coding | −5.50 | |
| 18 | LOC100576130 | NC_037647.1 (11434939..11439457, complement) | Diuretic hormone 44 | Protein coding | −5.26 | |
| 19 | LOC724900 | NC_037640.1 (12753760..12765869) | Uncharacterized LOC724900 | Protein coding | −5.01 | |
| 20 | LOC102654839 | NC_037651.1 (7556583..7571148) | Uncharacterized LOC102654839 | Protein coding | −4.97 | |
| 21 | LOC726459 | NC_037652.1 (7781687..7783890, complement) | Odorant receptor 13a | Protein coding | −4.94 | |
| 22 | crh-BP | NC_037645.1 (2187253..2195465, complement) | Corticotropin releasing hormone binding protein | Protein coding | −4.77 | |
| 23 | LOC727193 | NC_037648.1 (8288010..8291476, complement) | Lipase member H-A | Protein coding | −4.73 | |
| 24 | LOC113219002 | NC_037646.1 (2711025..2713806) | Uncharacterized LOC113219002 | Protein coding | −4.63 | |
| 25 | LOC551044 | NC_037642.1 (11669303..11678572) | Glucose dehydrogenase [FAD, quinone] | Protein coding | −4.58 | |
| 26 | LOC411894 | NC_037645.1 (12183077..12209596, complement) | Dynein beta chain, ciliary | Protein coding | −4.47 | K10408 |
| 27 | LOC413346 | NC_037638.1 (5691449..5701789, complement) | Endoglucanase E-4 | Protein coding | −4.06 | K01179 |
| 28 | LOC100577043 | NC_037638.1 (23246496..23248301) | Uncharacterized LOC100577043 | Protein coding | −4.02 | |
| 29 | LOC725264 | NC_037646.1 (4169782..4364474, complement) | Uncharacterized LOC725264 | Protein coding | −4.00 |
Figure 4Gene ontology (GO) analysis of differentially expressed genes (DEGs) from DWV-infected honey bee larvae with a fold change (fc) ≥ 2. In total, 909 DEGs were subjected to GO analysis, and 564 DEGs (65.1%) were categorized into three groups—molecular function, cellular component and biological process; however, 318 DEGs (34.9%) were unannotated in the GO database.
PANTHER gene ontology (GO) enrichment analysis of upregulated genes.
| Annotation data seta | GO term | No of genes | Fold enrichment | FDR¶ |
|---|---|---|---|---|
| Molecular function | Amino acid binding (GO:0016597) | 3 | 33.15 | 7.14E−02 |
| Organic acid binding (GO:0043177) | 3 | 25.9 | 7.01E−02 | |
| Carboxylic acid binding (GO:0031406) | 3 | 25.9 | 4.67E−02 |
Displaying only results for FDR p < 0.05.
¶p-value from Fisher's exact test with false discovery rate (FDR) correction for multiple testing.
aPANTHER GO-Slim analysis.
PANTHER gene ontology (GO) enrichment analysis of downregulated genes.
| Annotation data seta | GO term | No of genes | Fold enrichment | FDR¶ |
|---|---|---|---|---|
| Molecular function | Calcium ion binding (GO:0005509) | 9 | 6.76 | 2.76E−02 |
| Tetrapyrrole binding (GO:0046906) | 7 | 7.59 | 4.73E−02 | |
| Heme binding (GO:0020037) | 7 | 7.64 | 6.78E−02 | |
| Biological process | Cell adhesion (GO:0098602) | 9 | 7.81 | 2.47E−02 |
| Biological adhesion (GO:0022610) | 9 | 7.46 | 1.75E−02 | |
| Cell–cell adhesion (GO:0098609) | 7 | 9.84 | 2.62E−02 | |
| Cell–cell adhesion via plasma-membrane adhesion molecules (GO:0098742) | 6 | 12.65 | 2.29E−02 | |
| Cellular component | Cell periphery (GO:0071944) | 31 | 2.61 | 3.53E−04 |
| Intrinsic component of membrane (GO:0031224) | 22 | 2.27 | 1.99E−02 | |
| Plasma membrane (GO:0005886) | 22 | 2.36 | 1.63E−02 | |
| Intracellular anatomical structure (GO:0005622) | 21 | 0.49 | 1.81E−03 | |
| Extracellular region (GO:0005576) | 21 | 3.06 | 2.46E−03 | |
| Integral component of membrane (GO:0016021) | 21 | 2.21 | 3.29E−02 | |
| Organelle (GO:0043226) | 17 | 0.47 | 6.25E−03 | |
| Intracellular organelle (GO:0043229) | 14 | 0.41 | 1.50E−03 | |
| Membrane-bounded organelle (GO:0043227) | 14 | 0.44 | 8.08E−03 | |
| Intrinsic component of plasma membrane (GO:0031226) | 13 | 3.79 | 6.89E−03 | |
| Integral component of plasma membrane (GO:0005887) | 12 | 3.6 | 1.51E−02 | |
| Intracellular membrane-bounded organelle (GO:0043231) | 11 | 0.36 | 1.85E−03 | |
| External encapsulating structure (GO:0030312) | 9 | 4.45 | 2.10E−02 | |
| Extracellular matrix (GO:0031012) | 9 | 5 | 1.25E−02 | |
| Cell surface (GO:0009986) | 5 | 10.84 | 1.57E−02 | |
| Nucleus (GO:0005634) | 4 | 0.22 | 7.05E−03 | |
| Collagen-containing extracellular matrix (GO:0062023) | 4 | 14.12 | 1.94E−02 | |
| Basement membrane (GO:0005604) | 3 | 21.68 | 3.49E−02 | |
| External side of plasma membrane (GO:0009897) | 3 | 28.46 | 2.03E−02 |
Displaying only results for FDR P < 0.05.
¶p-value from Fisher's exact test with false discovery rate (FDR) correction for multiple testing.
aPANTHER GO-Slim analysis.
Figure 5Validation of upregulated genes at 0, 2, 4, 6 and 9 d.p.i. The mean ± SD was calculated for relative gene expression levels using the 2−ΔΔCt method (Livak &Schmittgen 2001). All experiments were performed in five replicates. *P < 0.05; **P < 0.01.
Figure 6Validation of downregulated genes at 0, 2, 4, 6 and 9 d.p.i. The mean ± SD was calculated for relative gene expression levels using the 2−ΔΔCt method (Livak &Schmittgen 2001). All experiments were performed in five replicates. *P < 0.05; **P < 0.01.